Dear All
GVK Bio and Quantitative solutions are pleased to announce that the no
of modeler ready Clinical Outcomes Databases has increased to eight
indications.
The databases available include:
i.
RA
ii.
Pain
iii.
Depression
iv.
Osteoporosis
v. HCV
vi.
Alzheimer's
vii.
Schizophrenia
viii.
Dyslipidemia
Additional indications are in the development phase.
Regards
Sreeni
Sreeni Devidas Ph.D.
Vice President Business Development
GVK BioSciences
5457 Twin Knolls Road
Suite 101
Columbia, MD 21045
Tel: 443-838-6260
Fax: (703) 940 4088
www.gvkbio.com http://www.gvkbio.com/
Notice: The information contained in this electronic mail message is intended
only for the use of the designated recipient. This message is privileged and
confidential. and the property of GVK BIO or its affiliates and subsidiaries.
If the reader of this message is not the intended recipient or an agent
responsible for delivering it to the intended recipient, you are hereby
notified that you have received this message in error and that any review,
dissemination, distribution, or copying of this message is strictly prohibited.
If you have received this communication in error, please notify us immediately
by telephone +91-40-66929999 and destroy any and all copies of this message in
your possession (whether hard copies or electronically stored copies).